カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のダウノルビシン市場2022年：静脈、点滴

◆英語タイトル：Global Daunorubicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8782）◆商品コード：GIR22MY8782
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：116
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ダウノルビシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のダウノルビシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ダウノルビシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・静脈、点滴

用途別セグメントは次のように区分されます。
・急性顆粒球、急性リンパ球白血病

世界のダウノルビシン市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi、Halison Pharmaceuiticals、Hikma Pharmaceuticals、Gilead Sciences、Bedford Pharmaceuticals、United Biotech、Mercian Corporation、Pharmacia、Cipla、TEVA、Medior Healthcare、West-Ward、Shandong Xinshidai Pharmaceutical、HISUN、Shenzhen Wanle Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ダウノルビシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なダウノルビシンメーカーの企業概要、2019年～2022年までのダウノルビシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なダウノルビシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ダウノルビシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのダウノルビシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのダウノルビシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびダウノルビシンの産業チェーンを掲載しています。
・第13、14、15章では、ダウノルビシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Halison Pharmaceuiticals、Hikma Pharmaceuticals、Gilead Sciences、Bedford Pharmaceuticals、United Biotech、Mercian Corporation、Pharmacia、Cipla、TEVA、Medior Healthcare、West-Ward、Shandong Xinshidai Pharmaceutical、HISUN、Shenzhen Wanle Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：静脈、点滴
・用途別分析2017年-2028年：急性顆粒球、急性リンパ球白血病
・ダウノルビシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ダウノルビシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ダウノルビシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ダウノルビシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ダウノルビシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Daunorubicin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Daunorubicin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Acute Granulocyte accounting for % of the Daunorubicin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intravenous segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Daunorubicin include Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, and Bedford Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Daunorubicin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intravenous
Drip
Market segment by Application can be divided into
Acute Granulocyte
Acute Lymphocyte Leukemia
The key market players for global Daunorubicin market are listed below:
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Daunorubicin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Daunorubicin, with price, sales, revenue and global market share of Daunorubicin from 2019 to 2022.
Chapter 3, the Daunorubicin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Daunorubicin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Daunorubicin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Daunorubicin.
Chapter 13, 14, and 15, to describe Daunorubicin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Daunorubicin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Daunorubicin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intravenous
1.2.3 Drip
1.3 Market Analysis by Application
1.3.1 Overview: Global Daunorubicin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Acute Granulocyte
1.3.3 Acute Lymphocyte Leukemia
1.4 Global Daunorubicin Market Size & Forecast
1.4.1 Global Daunorubicin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Daunorubicin Sales in Volume (2017-2028)
1.4.3 Global Daunorubicin Price (2017-2028)
1.5 Global Daunorubicin Production Capacity Analysis
1.5.1 Global Daunorubicin Total Production Capacity (2017-2028)
1.5.2 Global Daunorubicin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Daunorubicin Market Drivers
1.6.2 Daunorubicin Market Restraints
1.6.3 Daunorubicin Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Daunorubicin Product and Services
2.1.4 Sanofi Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Halison Pharmaceuiticals
2.2.1 Halison Pharmaceuiticals Details
2.2.2 Halison Pharmaceuiticals Major Business
2.2.3 Halison Pharmaceuiticals Daunorubicin Product and Services
2.2.4 Halison Pharmaceuiticals Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hikma Pharmaceuticals
2.3.1 Hikma Pharmaceuticals Details
2.3.2 Hikma Pharmaceuticals Major Business
2.3.3 Hikma Pharmaceuticals Daunorubicin Product and Services
2.3.4 Hikma Pharmaceuticals Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Daunorubicin Product and Services
2.4.4 Gilead Sciences Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bedford Pharmaceuticals
2.5.1 Bedford Pharmaceuticals Details
2.5.2 Bedford Pharmaceuticals Major Business
2.5.3 Bedford Pharmaceuticals Daunorubicin Product and Services
2.5.4 Bedford Pharmaceuticals Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 United Biotech
2.6.1 United Biotech Details
2.6.2 United Biotech Major Business
2.6.3 United Biotech Daunorubicin Product and Services
2.6.4 United Biotech Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mercian Corporation
2.7.1 Mercian Corporation Details
2.7.2 Mercian Corporation Major Business
2.7.3 Mercian Corporation Daunorubicin Product and Services
2.7.4 Mercian Corporation Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pharmacia
2.8.1 Pharmacia Details
2.8.2 Pharmacia Major Business
2.8.3 Pharmacia Daunorubicin Product and Services
2.8.4 Pharmacia Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Daunorubicin Product and Services
2.9.4 Cipla Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 TEVA
2.10.1 TEVA Details
2.10.2 TEVA Major Business
2.10.3 TEVA Daunorubicin Product and Services
2.10.4 TEVA Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Medior Healthcare
2.11.1 Medior Healthcare Details
2.11.2 Medior Healthcare Major Business
2.11.3 Medior Healthcare Daunorubicin Product and Services
2.11.4 Medior Healthcare Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 West-Ward
2.12.1 West-Ward Details
2.12.2 West-Ward Major Business
2.12.3 West-Ward Daunorubicin Product and Services
2.12.4 West-Ward Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shandong Xinshidai Pharmaceutical
2.13.1 Shandong Xinshidai Pharmaceutical Details
2.13.2 Shandong Xinshidai Pharmaceutical Major Business
2.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Product and Services
2.13.4 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 HISUN
2.14.1 HISUN Details
2.14.2 HISUN Major Business
2.14.3 HISUN Daunorubicin Product and Services
2.14.4 HISUN Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shenzhen Wanle Pharmaceutical
2.15.1 Shenzhen Wanle Pharmaceutical Details
2.15.2 Shenzhen Wanle Pharmaceutical Major Business
2.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Product and Services
2.15.4 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Daunorubicin Breakdown Data by Manufacturer
3.1 Global Daunorubicin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Daunorubicin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Daunorubicin
3.4 Market Concentration Rate
3.4.1 Top 3 Daunorubicin Manufacturer Market Share in 2021
3.4.2 Top 6 Daunorubicin Manufacturer Market Share in 2021
3.5 Global Daunorubicin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Daunorubicin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Daunorubicin Market Size by Region
4.1.1 Global Daunorubicin Sales in Volume by Region (2017-2028)
4.1.2 Global Daunorubicin Revenue by Region (2017-2028)
4.2 North America Daunorubicin Revenue (2017-2028)
4.3 Europe Daunorubicin Revenue (2017-2028)
4.4 Asia-Pacific Daunorubicin Revenue (2017-2028)
4.5 South America Daunorubicin Revenue (2017-2028)
4.6 Middle East and Africa Daunorubicin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Daunorubicin Sales in Volume by Type (2017-2028)
5.2 Global Daunorubicin Revenue by Type (2017-2028)
5.3 Global Daunorubicin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Daunorubicin Sales in Volume by Application (2017-2028)
6.2 Global Daunorubicin Revenue by Application (2017-2028)
6.3 Global Daunorubicin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Daunorubicin Sales by Type (2017-2028)
7.2 North America Daunorubicin Sales by Application (2017-2028)
7.3 North America Daunorubicin Market Size by Country
7.3.1 North America Daunorubicin Sales in Volume by Country (2017-2028)
7.3.2 North America Daunorubicin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Daunorubicin Sales by Type (2017-2028)
8.2 Europe Daunorubicin Sales by Application (2017-2028)
8.3 Europe Daunorubicin Market Size by Country
8.3.1 Europe Daunorubicin Sales in Volume by Country (2017-2028)
8.3.2 Europe Daunorubicin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Daunorubicin Sales by Type (2017-2028)
9.2 Asia-Pacific Daunorubicin Sales by Application (2017-2028)
9.3 Asia-Pacific Daunorubicin Market Size by Region
9.3.1 Asia-Pacific Daunorubicin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Daunorubicin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Daunorubicin Sales by Type (2017-2028)
10.2 South America Daunorubicin Sales by Application (2017-2028)
10.3 South America Daunorubicin Market Size by Country
10.3.1 South America Daunorubicin Sales in Volume by Country (2017-2028)
10.3.2 South America Daunorubicin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Daunorubicin Sales by Type (2017-2028)
11.2 Middle East & Africa Daunorubicin Sales by Application (2017-2028)
11.3 Middle East & Africa Daunorubicin Market Size by Country
11.3.1 Middle East & Africa Daunorubicin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Daunorubicin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Daunorubicin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Daunorubicin
12.3 Daunorubicin Production Process
12.4 Daunorubicin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Daunorubicin Typical Distributors
13.3 Daunorubicin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Daunorubicin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Daunorubicin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Daunorubicin Product and Services
Table 6. Sanofi Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Halison Pharmaceuiticals Basic Information, Manufacturing Base and Competitors
Table 8. Halison Pharmaceuiticals Major Business
Table 9. Halison Pharmaceuiticals Daunorubicin Product and Services
Table 10. Halison Pharmaceuiticals Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Hikma Pharmaceuticals Major Business
Table 13. Hikma Pharmaceuticals Daunorubicin Product and Services
Table 14. Hikma Pharmaceuticals Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 16. Gilead Sciences Major Business
Table 17. Gilead Sciences Daunorubicin Product and Services
Table 18. Gilead Sciences Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bedford Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Bedford Pharmaceuticals Major Business
Table 21. Bedford Pharmaceuticals Daunorubicin Product and Services
Table 22. Bedford Pharmaceuticals Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. United Biotech Basic Information, Manufacturing Base and Competitors
Table 24. United Biotech Major Business
Table 25. United Biotech Daunorubicin Product and Services
Table 26. United Biotech Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Mercian Corporation Basic Information, Manufacturing Base and Competitors
Table 28. Mercian Corporation Major Business
Table 29. Mercian Corporation Daunorubicin Product and Services
Table 30. Mercian Corporation Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pharmacia Basic Information, Manufacturing Base and Competitors
Table 32. Pharmacia Major Business
Table 33. Pharmacia Daunorubicin Product and Services
Table 34. Pharmacia Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Cipla Basic Information, Manufacturing Base and Competitors
Table 36. Cipla Major Business
Table 37. Cipla Daunorubicin Product and Services
Table 38. Cipla Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. TEVA Basic Information, Manufacturing Base and Competitors
Table 40. TEVA Major Business
Table 41. TEVA Daunorubicin Product and Services
Table 42. TEVA Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Medior Healthcare Basic Information, Manufacturing Base and Competitors
Table 44. Medior Healthcare Major Business
Table 45. Medior Healthcare Daunorubicin Product and Services
Table 46. Medior Healthcare Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. West-Ward Basic Information, Manufacturing Base and Competitors
Table 48. West-Ward Major Business
Table 49. West-Ward Daunorubicin Product and Services
Table 50. West-Ward Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Shandong Xinshidai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Shandong Xinshidai Pharmaceutical Major Business
Table 53. Shandong Xinshidai Pharmaceutical Daunorubicin Product and Services
Table 54. Shandong Xinshidai Pharmaceutical Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. HISUN Basic Information, Manufacturing Base and Competitors
Table 56. HISUN Major Business
Table 57. HISUN Daunorubicin Product and Services
Table 58. HISUN Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Shenzhen Wanle Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Shenzhen Wanle Pharmaceutical Major Business
Table 61. Shenzhen Wanle Pharmaceutical Daunorubicin Product and Services
Table 62. Shenzhen Wanle Pharmaceutical Daunorubicin Sales (Litre), Price (US$/Litre), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Daunorubicin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Litre)
Table 64. Global Daunorubicin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Daunorubicin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Daunorubicin Production Capacity by Company, (Litre): 2020 VS 2021
Table 67. Head Office and Daunorubicin Production Site of Key Manufacturer
Table 68. Daunorubicin New Entrant and Capacity Expansion Plans
Table 69. Daunorubicin Mergers & Acquisitions in the Past Five Years
Table 70. Global Daunorubicin Sales by Region (2017-2022) & (Litre)
Table 71. Global Daunorubicin Sales by Region (2023-2028) & (Litre)
Table 72. Global Daunorubicin Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Daunorubicin Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 75. Global Daunorubicin Sales by Type (2023-2028) & (Litre)
Table 76. Global Daunorubicin Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Daunorubicin Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Daunorubicin Price by Type (2017-2022) & (US$/Litre)
Table 79. Global Daunorubicin Price by Type (2023-2028) & (US$/Litre)
Table 80. Global Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 81. Global Daunorubicin Sales by Application (2023-2028) & (Litre)
Table 82. Global Daunorubicin Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Daunorubicin Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Daunorubicin Price by Application (2017-2022) & (US$/Litre)
Table 85. Global Daunorubicin Price by Application (2023-2028) & (US$/Litre)
Table 86. North America Daunorubicin Sales by Country (2017-2022) & (Litre)
Table 87. North America Daunorubicin Sales by Country (2023-2028) & (Litre)
Table 88. North America Daunorubicin Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Daunorubicin Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 91. North America Daunorubicin Sales by Type (2023-2028) & (Litre)
Table 92. North America Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 93. North America Daunorubicin Sales by Application (2023-2028) & (Litre)
Table 94. Europe Daunorubicin Sales by Country (2017-2022) & (Litre)
Table 95. Europe Daunorubicin Sales by Country (2023-2028) & (Litre)
Table 96. Europe Daunorubicin Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Daunorubicin Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 99. Europe Daunorubicin Sales by Type (2023-2028) & (Litre)
Table 100. Europe Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 101. Europe Daunorubicin Sales by Application (2023-2028) & (Litre)
Table 102. Asia-Pacific Daunorubicin Sales by Region (2017-2022) & (Litre)
Table 103. Asia-Pacific Daunorubicin Sales by Region (2023-2028) & (Litre)
Table 104. Asia-Pacific Daunorubicin Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Daunorubicin Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 107. Asia-Pacific Daunorubicin Sales by Type (2023-2028) & (Litre)
Table 108. Asia-Pacific Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 109. Asia-Pacific Daunorubicin Sales by Application (2023-2028) & (Litre)
Table 110. South America Daunorubicin Sales by Country (2017-2022) & (Litre)
Table 111. South America Daunorubicin Sales by Country (2023-2028) & (Litre)
Table 112. South America Daunorubicin Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Daunorubicin Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 115. South America Daunorubicin Sales by Type (2023-2028) & (Litre)
Table 116. South America Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 117. South America Daunorubicin Sales by Application (2023-2028) & (Litre)
Table 118. Middle East & Africa Daunorubicin Sales by Region (2017-2022) & (Litre)
Table 119. Middle East & Africa Daunorubicin Sales by Region (2023-2028) & (Litre)
Table 120. Middle East & Africa Daunorubicin Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Daunorubicin Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Daunorubicin Sales by Type (2017-2022) & (Litre)
Table 123. Middle East & Africa Daunorubicin Sales by Type (2023-2028) & (Litre)
Table 124. Middle East & Africa Daunorubicin Sales by Application (2017-2022) & (Litre)
Table 125. Middle East & Africa Daunorubicin Sales by Application (2023-2028) & (Litre)
Table 126. Daunorubicin Raw Material
Table 127. Key Manufacturers of Daunorubicin Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Daunorubicin Typical Distributors
Table 131. Daunorubicin Typical Customers
List of Figures
Figure 1. Daunorubicin Picture
Figure 2. Global Daunorubicin Revenue Market Share by Type in 2021
Figure 3. Intravenous
Figure 4. Drip
Figure 5. Global Daunorubicin Revenue Market Share by Application in 2021
Figure 6. Acute Granulocyte
Figure 7. Acute Lymphocyte Leukemia
Figure 8. Global Daunorubicin Revenue, (USD Million) & (Litre): 2017 & 2021 & 2028
Figure 9. Global Daunorubicin Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Daunorubicin Sales (2017-2028) & (Litre)
Figure 11. Global Daunorubicin Price (2017-2028) & (US$/Litre)
Figure 12. Global Daunorubicin Production Capacity (2017-2028) & (Litre)
Figure 13. Global Daunorubicin Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Daunorubicin Market Drivers
Figure 15. Daunorubicin Market Restraints
Figure 16. Daunorubicin Market Trends
Figure 17. Global Daunorubicin Sales Market Share by Manufacturer in 2021
Figure 18. Global Daunorubicin Revenue Market Share by Manufacturer in 2021
Figure 19. Daunorubicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Daunorubicin Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Daunorubicin Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Daunorubicin Sales Market Share by Region (2017-2028)
Figure 23. Global Daunorubicin Revenue Market Share by Region (2017-2028)
Figure 24. North America Daunorubicin Revenue (2017-2028) & (USD Million)
Figure 25. Europe Daunorubicin Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Daunorubicin Revenue (2017-2028) & (USD Million)
Figure 27. South America Daunorubicin Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Daunorubicin Revenue (2017-2028) & (USD Million)
Figure 29. Global Daunorubicin Sales Market Share by Type (2017-2028)
Figure 30. Global Daunorubicin Revenue Market Share by Type (2017-2028)
Figure 31. Global Daunorubicin Price by Type (2017-2028) & (US$/Litre)
Figure 32. Global Daunorubicin Sales Market Share by Application (2017-2028)
Figure 33. Global Daunorubicin Revenue Market Share by Application (2017-2028)
Figure 34. Global Daunorubicin Price by Application (2017-2028) & (US$/Litre)
Figure 35. North America Daunorubicin Sales Market Share by Type (2017-2028)
Figure 36. North America Daunorubicin Sales Market Share by Application (2017-2028)
Figure 37. North America Daunorubicin Sales Market Share by Country (2017-2028)
Figure 38. North America Daunorubicin Revenue Market Share by Country (2017-2028)
Figure 39. United States Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Daunorubicin Sales Market Share by Type (2017-2028)
Figure 43. Europe Daunorubicin Sales Market Share by Application (2017-2028)
Figure 44. Europe Daunorubicin Sales Market Share by Country (2017-2028)
Figure 45. Europe Daunorubicin Revenue Market Share by Country (2017-2028)
Figure 46. Germany Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Daunorubicin Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Daunorubicin Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Daunorubicin Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Daunorubicin Revenue Market Share by Region (2017-2028)
Figure 55. China Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Daunorubicin Sales Market Share by Type (2017-2028)
Figure 62. South America Daunorubicin Sales Market Share by Application (2017-2028)
Figure 63. South America Daunorubicin Sales Market Share by Country (2017-2028)
Figure 64. South America Daunorubicin Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Daunorubicin Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Daunorubicin Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Daunorubicin Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Daunorubicin Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Daunorubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Daunorubicin in 2021
Figure 76. Manufacturing Process Analysis of Daunorubicin
Figure 77. Daunorubicin Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のダウノルビシン市場2022年：静脈、点滴(Global Daunorubicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のサーモガン市場2022年：接触、非接触
  • 世界の移動式DR市場2022年：手動、電気、遠隔制御ドライブ
  • 世界のライビズマブ・バイオシミラー市場2022年：AMD、CNV、DME
  • 世界のBGM（血糖測定）＆CGM（持続血糖測定）市場2022年：血糖測定、持続血糖測定
  • 世界の携帯型レスピレーター市場2022年：定圧式レスピレーター、定容量式レスピレーター、タイミング式レスピレーター、混合式レスピレーター